CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,483,626 | -18.2% | 287,971 | -9.5% | 0.00% | 0.0% |
| Q2 2023 | $10,376,552 | +10.5% | 318,104 | +19.2% | 0.00% | 0.0% |
| Q1 2023 | $9,393,267 | -38.8% | 266,930 | -20.4% | 0.00% | -50.0% |
| Q4 2022 | $15,359,643 | +50.3% | 335,217 | +58.9% | 0.01% | +50.0% |
| Q3 2022 | $10,218,000 | +58.1% | 210,897 | +28.2% | 0.00% | +33.3% |
| Q2 2022 | $6,463,000 | -29.2% | 164,482 | -33.7% | 0.00% | 0.0% |
| Q1 2022 | $9,130,000 | -18.0% | 248,022 | +1.5% | 0.00% | 0.0% |
| Q4 2021 | $11,139,000 | +131.7% | 244,373 | +81.7% | 0.00% | +50.0% |
| Q3 2021 | $4,807,000 | +810.4% | 134,504 | +404.7% | 0.00% | – |
| Q2 2021 | $528,000 | -74.3% | 26,650 | -69.8% | 0.00% | -100.0% |
| Q1 2021 | $2,053,000 | +3010.6% | 88,254 | +2690.2% | 0.00% | – |
| Q4 2020 | $66,000 | +20.0% | 3,163 | +26.0% | 0.00% | – |
| Q3 2020 | $55,000 | 0.0% | 2,511 | +6.8% | 0.00% | – |
| Q2 2020 | $55,000 | -77.0% | 2,352 | -88.4% | 0.00% | – |
| Q1 2020 | $239,000 | -56.7% | 20,289 | -61.0% | 0.00% | – |
| Q4 2019 | $552,000 | -50.2% | 52,086 | -46.5% | 0.00% | – |
| Q3 2019 | $1,108,000 | +357.9% | 97,361 | +352.3% | 0.00% | – |
| Q2 2019 | $242,000 | +505.0% | 21,528 | +334.1% | 0.00% | – |
| Q1 2019 | $40,000 | -92.3% | 4,959 | -93.9% | 0.00% | – |
| Q4 2018 | $517,000 | +660.3% | 81,798 | +1079.0% | 0.00% | – |
| Q3 2018 | $68,000 | +423.1% | 6,938 | +344.5% | 0.00% | – |
| Q2 2018 | $13,000 | -96.7% | 1,561 | -97.2% | 0.00% | – |
| Q1 2018 | $396,000 | +189.1% | 54,910 | +226.7% | 0.00% | – |
| Q4 2017 | $137,000 | -62.0% | 16,805 | -32.4% | 0.00% | – |
| Q3 2017 | $361,000 | +652.1% | 24,852 | +527.4% | 0.00% | – |
| Q2 2017 | $48,000 | -73.8% | 3,961 | -72.3% | 0.00% | – |
| Q1 2017 | $183,000 | +23.6% | 14,281 | +16.9% | 0.00% | – |
| Q4 2016 | $148,000 | +270.0% | 12,221 | +184.1% | 0.00% | – |
| Q3 2016 | $40,000 | +66.7% | 4,301 | +71.0% | 0.00% | – |
| Q2 2016 | $24,000 | +33.3% | 2,515 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | -94.0% | 2,515 | -91.2% | 0.00% | – |
| Q4 2015 | $298,000 | +1652.9% | 28,490 | +1019.9% | 0.00% | – |
| Q3 2015 | $17,000 | -19.0% | 2,544 | -18.5% | 0.00% | – |
| Q2 2015 | $21,000 | +23.5% | 3,123 | +22.8% | 0.00% | – |
| Q1 2015 | $17,000 | -64.6% | 2,544 | -57.3% | 0.00% | – |
| Q4 2014 | $48,000 | – | 5,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |